Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Mylan“
Suchtreffer
Begriffe & Kennungen
Ambrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Rifampicin
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Steady-state administration of ambrisentan in healthy volunteers had no clinically relevant effects on the sin
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Steady-state administration of ketoconazole (a strong inhibitor of CYP3A4) did not result in a clinically sign
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Steady-state co-administration of ambrisentan and cyclosporine A resulted in a 2-fold increase in ambrisentan
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · The efficacy and safety of ambrisentan when co-administered with other treatments for PAH (e.g. prostanoids an
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · The potential for ambrisentan to induce CYP3A4 activity was explored in healthy volunteers with results sugges
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 Undesirable effects · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · 8 System organ class Frequency Adverse reaction(s) Respiratory, thoracic and Very common Dyspnoea6, mediastina
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Decreased haemoglobin In the post-marketing period, cases of anaemia requiring blood cell transfusion have bee
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Description of selected adverse reactions
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1 000 to <1/100); rare
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Hepatic enzyme elevations (2%), hepatic injury and autoimmune hepatitis (including exacerbation of underlying
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Peripheral oedema (37%) and headache (28%) were the most common adverse reactions observed with ambrisentan. T
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reductions in haemoglobin concentrations and haematocrit (10%) have been associated with ERAs including ambris
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Serious adverse reactions associated with ambrisentan use include anaemia (decreased haemoglobin, decreased ha
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Summary of the safety profile
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · System organ class Frequency Adverse reaction(s) Blood and lymphatic system Very common Anaemia (decreased hae
Eintrag öffnen